Galecto Inc
NASDAQ:GLTO
Galecto Inc
PP&E Net
Galecto Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
PP&E Net
$325k
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
PP&E Net
kr1.9B
|
CAGR 3-Years
30%
|
CAGR 5-Years
38%
|
CAGR 10-Years
56%
|
|
Zealand Pharma A/S
CSE:ZEAL
|
PP&E Net
kr149.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
57%
|
CAGR 10-Years
22%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
PP&E Net
€107.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
PP&E Net
kr2.4B
|
CAGR 3-Years
27%
|
CAGR 5-Years
30%
|
CAGR 10-Years
22%
|
Bioporto A/S
CSE:BIOPOR
|
PP&E Net
kr1.6m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
11%
|
See Also
What is Galecto Inc's PP&E Net?
PP&E Net
325k
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's PP&E Net amounts to 325k USD.
What is Galecto Inc's PP&E Net growth rate?
PP&E Net CAGR 3Y
-29%
Over the last year, the PP&E Net growth was -73%. The average annual PP&E Net growth rates for Galecto Inc have been -29% over the past three years .